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Abstract
 
During ageing thymic function declines and is unable to meet the demand for peripheral T
helper (Th) cell replenishment. Therefore, population maintenance of naive Th cells must be at
least partly peripherally based. Such peripheral postthymic expansion of recent thymic emi-
grants (RTEs) during ageing consequently should lead to loss or dilution of T cell receptor ex-
cision circles (TRECs) from a subset of naive T cells. We have identified two subsets of naive
Th cells in human adult peripheral blood characterized by a striking unequal content of
TRECs, indicating different peripheral proliferative histories. TRECs are highly enriched in
 
peripheral naive CD45RA
 
 
 
 Th cells coexpressing CD31 compared with peripheral naive
CD45RA
 
 
 
 Th cells lacking CD31 expression, in which TRECs can hardly be detected. Fur-
thermore we show that CD31
 
 
 
CD45RA
 
 
 
 Th cells account for increasing percentages of the
naive peripheral Th cell pool during ageing but retain phenotypic and functional features of na-
ive Th cells. As CD31 is lost upon T cell receptor (TCR) engagement in vitro, we hypothesize
that TCR triggering is a prerequisite for homeostatically driven peripheral postthymic expan-
sion of human naive RTEs. We describe here the identification of peripherally expanded naive
Th cells in human adult blood characterized by the loss of CD31 expression and a highly re-
duced TREC content.
Key words: CD31 • naive Th cells • Th cell homeostasis • recent thymic emigrants • 
peripheral Th cell pool
 
Introduction
 
The size of the recirculating naive T cell pool remains rela-
tively constant throughout adult life in spite of continuous
environmental antigenic stimulation and a dramatic reduc-
tion in production of naive T cells in the thymus with age
(1–3). The presence of a great number of naive T cells
within CD4
 
 
 
 and CD8
 
 
 
 T cell subsets even in the periph-
eral blood of centenarians is thus puzzling. Extensive stud-
ies in the murine system revealed that subsets of recent thy-
mic emigrants (RTEs) proliferate in response to triggering
via MHC molecules presenting self-peptides (4–6) depend-
ing on the TCR affinity for the MHC–peptide complexes.
In this manner, subsets of naive RTEs are positively se-
lected a second time before they are allowed to enter a
“second” pool of naive Th cells. In addition, cytokines
such as IL-7 and IL-15 play an important role in the post-
thymic expansion of peripheral naive Th cells (7–10).
RTEs have been identified recently by analyzing T cell
receptor excision circles (TRECs), which are stable DNA
episomes formed during T cell receptor rearrangement in
at least 70% of 
 
  
 
 
 
 Th cells (2,3, 11–14). As TRECs are
not replicated during mitosis they are diluted out during
cell divisions (11, 15), which include priming of RTEs to
become memory Th cells but also homeostatic cell division
of naive Th cells. Interestingly, TREC numbers among
CD4
 
 
 
 Th cells decrease 50 to 100 times during ageing (2,
3), while absolute numbers of naive CD4
 
 
 
 Th cells, as
characterized by expression of CD45RA, decrease only by
a factor of 2 or 3 with age (16, 17). This implies extensive
peripheral expansion of naive Th cells during ageing. Such
homeostasis-driven expansion of naive T cells, which is
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most obvious in lymphopenic environments, requires spe-
cific TCR interaction with self-peptide/MHC.
Here we addressed the issue whether homeostasis driven
proliferation results in a second subset of naive Th cells. To
distinguish RTEs from peripherally expanded naive Th
cells we searched for cell surface molecules with an altered
expression pattern after TCR triggering on Th cells. Ap-
parently such TCR engagement does not alter the expres-
sion of molecules, which have been used widely to charac-
terize human naive Th cells as CD27 and CD62L, as these
markers are coexpressed by the majority of CD45RA
 
 
 
 Th
cells in adult peripheral blood lacking CD45RO expression
(data not shown). Only CD31 (platelet endothelial cell
adhesion molecule-1 [PECAM-1]) meets these criteria:
CD31 is lost after TCR triggering in vitro and has been
shown to be differentially expressed among peripheral Th
cells in healthy donors (18–21). Hence, we examined
whether frequencies of CD45RA
 
 
 
 Th cells lacking CD31
expression change during ageing and whether they differ in
phenotypic or functional characteristics from CD31
 
 
 
CD45RA
 
 
 
 Th cells. We finally assessed directly the TREC
content in CD31-expressing and CD31-nonexpressing
CD45RA
 
 
 
 Th cells highly purified from adult peripheral
blood in order to determine the frequency of recent thymic
emigrants among these two subsets of naive Th cells in hu-
man adult peripheral blood.
 
Materials and Methods
 
Blood Samples.
 
Peripheral blood samples were obtained from
adult healthy donors (blood bank Virchow Klinikum, Humboldt
Universität Berlin, Berlin, Germany). Umbilical cord blood sam-
ples were obtained directly after birth (Virchow Klinikum, Hum-
boldt Universität Berlin).
 
Isolation of PBMCs and Cord Blood Mononuclear Cells.
 
PBMCs
were obtained from peripheral blood and cord blood mononu-
clear cells (CBMCs) were obtained from cord blood by density
gradient sedimentation using Ficoll/Hypaque (Sigma-Aldrich).
Cells were washed twice with PBS before staining with mAbs for
flow cytometry or cell sorting.
 
Magnetic Activated Cell Sorting.
 
CD4
 
 
 
 Th cells were enriched
to high purity (
 
 
 
98%) from PBMCs or CMBCs by magnetic
separation using releasable CD4-MultiSort-Microbeads (Mil-
tenyi Biotec). After release of the CD4-MultiSort-Microbeads
the CD4
 
 
 
 T cells were depleted with CD45RO-Microbeads
(Miltenyi Biotec) to obtain pure CD45RA
 
 
 
CD45RO
 
 
 
 T cells.
These cells were then separated in a third magnetic separation
step into CD31
 
 
 
 and CD31
 
 
 
CD45RA
 
 
 
 Th subpopulations after
staining with anti-CD31-FITC (Becton Dickinson) and subse-
quent labeling with anti-FITC-Microbeads (Miltenyi Biotec).
The purities of these two populations were at least 95%.
 
Immunophenotypic Analysis and Cell Sorting by Flow Cytometry.
 
For immunophenotypic analysis, PBMCs or CD4
 
 
 
 Th cells (iso-
lated by magnetic activated cell sorting [MACS]) were quadruple
stained with fluorescent-conjugated mAbs specific for cell surface
markers and analyzed by flow cytometry using a FACSCalibur™
(Becton Dickinson). FITC-labeled anti-CD7, anti-CD11a, anti-
CD26, anti-CD44, anti-CD45RA, anti-CD45RB, anti-CD62L,
anti-CD95, anti-HLA-DR, PE-labeled anti-CD31, PerCP-
labeled anti-CD4, and allophycocyanin (APC)-labeled anti-
 
CD45RO were purchased from BD PharMingen. Monoclonal
antibody 2E4 (anti-CD27) was a generous gift from René van
Lier (Clinical Immunology Laboratory, Academic Medical Cen-
ter, Amsterdam, Netherlands). Purified anti-CD27 was conju-
gated to Cy5 (Amersham Pharmacia Biotech). After gating on
CD4
 
 
 
 or CD45RA
 
 
 
 CD45RO
 
 
 
 Th cells lymphocyte data was
analyzed with CELLQuest™ software (Becton Dickinson). For
purification of CD31
 
 
 
 and CD31
 
 
 
CD45RA
 
 
 
CD45RO
 
 
 
 and
CD31
 
 
 
CD45RA
 
 
 
CD45RO
 
 
 
 Th subsets CD4
 
 
 
 Th cells were
isolated from PBMCs by MACS as described above. The CD4
 
 
 
Th cells were stained with mAbs specific for CD31, CD45RA,
and CD45RO and further separated by a FACSVantage™ (Bec-
ton Dickinson) into CD31
 
 
 
 and CD31
 
 
 
CD45RA
 
 
 
CD45RO
 
 
 
and CD31
 
 
 
CD45RA
 
 
 
CD45RO
 
 
 
 Th cells. Reanalysis of the
isolated subsets using a FACSCalibur™ (Becton Dickinson)
showed that the purities were at least 91% (data not shown).
 
Polyclonal In Vitro Stimulation and Intracellular Cytokine Stain-
ing.
 
Highly purified CD31
 
 
 
 and CD31
 
 
 
CD45RA
 
 
 
CD45RO
 
 
 
and CD31
 
 
 
CD45RA
 
 
 
CD45RO
 
 
 
 Th cells were counted and
10
 
6
 
 cells/ml were cultured for 6 h in the presence of 5 ng/ml
PMA (Sigma-Aldrich) and 1 ng/ml ionomycin (Sigma-Aldrich),
with the secretion inhibitor brefeldin-A (Sigma-Aldrich) added
during the last 2 h. The cells were then fixed with 2% formalin,
stained with mAbs specific for IL-2, IFN-
 
 
 
, and IL-4 (BD
PharMingen), and cytokine positive cells were quantified by flow
cytometry using a FACSCalibur™ (Becton Dickinson).
 
Quantification of TRECs by Real-time PCR.
 
The number of
TRECs was determined by quantitative real-time PCR using the
ABI PRISM 7700 Sequence Detector TaqMan (PE Biosystems).
In this PCR binding of a specific probe, containing a quencher
(TAMRA) and a reporter (6FAM) dye, to the amplification
products results in Taq DNA polymerase mediated cleavage of
the probe. This leads to separation of the quencher from the re-
porter, thereby inducing fluorescence of the reporter dye. The
amount of target in analyzed samples is established by measuring
the threshold cycle (C
 
T
 
), defined as the fractional cycle number at
which the fluorescence generated by cleavage of the probe passes
a fixed threshold above baseline, and using the standard curve to
determine starting copy number. To precisely determine the per-
centage of cells carrying TREC a duplex vector was constructed,
containing a fragment of the 
 
 
 
Rec-
 
 
 
J
 
 
 
 signal joint (TREC) and
a fragment of the RAG2 gene, used as a reference. The RAG2
was cloned first in the T-A acceptor site and subsequently the
TREC was cloned into the EcoRV restriction site of the TOPO
TA Vector (Invitrogen). Based on the DNA concentration, mea-
sured by spectrophotometry and confirmed by a quantitative gel
electrophoresis, standard dilutions of the vector from 10
 
7
 
 to 10
 
1
 
copies were prepared. In brief, PCR of 50 
 
 
 
l total volume was
performed with 
 
 
 
100 ng of genomic DNA, 25 pmol of each
primers, 10 nmol each dNTP (PerkinElmer), 1.25 U Platinium
Taq polymerase (Life Technologies), 5 pmol of 6FAM-TAMRA
probe, and PCR buffer including 4.5 mM MgCl
 
2
 
 (Life Technol-
ogies). After the initial denaturation at 95
 
 
 
C for 5
 
 
 
, 45 cycles
consisting of 95
 
 
 
C for 30 s and 66
 
 
 
C for 30 s were performed.
For TREC analysis the 5
 
 
 
 primer 
 
 
 
J
 
 
 
 (-258): AAC AGC CTT
TGG GAC ACT ATC G and the 3
 
 
 
 primer 
 
 
 
Recsj(
 
 
 
104): AAC
AGC CTT TGG GAC ACT ATC G, amplifying the signal joint
sequence generated by the 
 
 
 
Rec-
 
 
 
J
 
 
 
 rearrangement, were used
together with the TREC probe: 6FAM-CCA CAT CCC TTT
CAA CCA TGC TGA TGA CAC CTC T-TAMRA. For
RAG2 analysis the 5
 
 
 
 primer: RAG2(2160) GCA ACA TGG
GAA ATG GAA CTG, the 3
 
 
 
 primer: RAG2(2404) GGT GTC
AAA TTC ATC ATC ACC ATC and the RAG2 probe: 
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6FAM-CCC CTG GAT CTT CTG TTG ATG TTT GAC
TGT TTG TGA-TAMRA were used.
 
Results
 
Frequencies of CD31
 
 
 
 and CD31
 
 
 
CD45RA
 
 
 
 Th Cells
during Ageing.
 
At first, we examined whether frequencies
of CD45RA
 
 
 
 Th cells coexpressing the CD31 molecule
change with ageing. We observed drastic changes: CD31
coexpression was high (85–90%) in CD45RA
 
 
 
 Th-cells
from children (younger than 15 yr of age) but decreased
constantly during ageing, from 60–80% in 20–30-yr-old
adults down to 40–60% in adults older than 60 yr (Fig. 1).
The concomitant age dependent expansion of peripheral
CD45RA
 
 
 
 Th cells lacking CD31 expression correlates
with the increased requirement for thymus independent
peripheral expansion of naive Th cells in response to the
reduced output of RTEs in elderly people. However, it
would also correlate with increasing frequencies of mem-
ory/effector Th cells with regaining CD45RA expression.
 
Phenotypic Analysis of CD31
 
 
 
 and CD31
 
 
 
CD45RA
 
 
 
 Th
Cells.
 
To investigate whether these expanded CD45RA
 
 
 
Th cells could represent increasing frequencies of memory/
effector Th cells with regaining CD45RA expression, we
next analyzed the expression of CD7, CD11a, CD26,
CD27, CD44, CD45RB, CD62L, CD95, HLA-DR on
purified indicated CD4
 
 
 
 Th cell subsets. CD31
 
 
 
CD45RA
 
 
 
 Th cells phenotypically resemble naive Th
cells: they do not coexpress the CD45RO and they are not
characterized by elevated levels of CD11a or CD44. Only a
few cells (
 
 
 
1%) have lost CD7, CD26, CD27, or CD62L
expression (Fig. 2) and thus represent memory/effector Th
cells with regaining CD45RA expression. As expected
such specialized CD45RA
 
 
 
 memory/effector Th cells are
rare in peripheral blood of healthy adults. Hence, CD31
 
 
 
and CD31
 
 
 
CD45RA
 
 
 
 Th cells both correspond pheno-
typically to naive Th cells.
Figure 1. Frequencies of CD31  Th cells among the
CD45RA CD45RO  Th cells during ageing. CD4  Th cells were iso-
lated from PBMCs by MACS. The CD4  Th cells were stained with
mAbs specific for CD31, CD45RA, and CD45RO and analyzed by flow
cytometry. Gray points indicate the relative frequency of CD31  Th cells
among the CD45RA CD45RO  Th cells in individual samples. The
linear regression curve is shown. There is a significant negative correla-
tion between the age and the frequency of CD31  Th cells among the
CD45RA CD45RO  Th cell subset (r    0.875).
Figure 2. Phenotypic characterization of CD31  and
CD31 CD45RA   Th cells (B and C) in comparison to
CD45RO  Th cells (A). The dot plot (a) shows the expression
of the cell surface molecules CD45RO and CD45RA, the dot
plot (b) shows the expression of the cell surface molecules CD31
and CD45RA among peripheral CD4  Th cells. PBMCs from
a healthy donor were stained with anti-CD4, anti-CD45RA,
anti-CD45RO, and anti-CD31 mAbs and examined by flow
cytometry. The cells in a and b are gated on scatter and CD4 
Th cells. The histograms (c–k) show the expression of the cell
surface molecules CD7, CD11a, CD26, CD27, CD44,
CD45RB, CD62L, CD95, HLA-DR by peripheral blood
CD45RO  Th cells (fine line A), CD31 CD45RA  Th cells
(dotted line B) and CD31 CD45RA  Th cells (bold line C)
in one healthy donor (representative for three analyzed healthy
individuals). PBMCs were stained with mAbs against CD4,
CD45RO, CD31, and one of the surface markers (indicated in
each plot) and examined by flow cytometry. 
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Cytokine Program of CD31
 
 
 
 and CD31
 
 
 
CD45RA
 
 
 
 Th
Cells.
 
We also analyzed the functional potential of both
CD31
 
 
 
 and CD31
 
 
 
 CD45RA
 
 
 
 Th cells according to their
cytokine secretion profiles after polyclonal in vitro stimula-
tion. CD31
 
 
 
 and CD31
 
 
 
CD45RA
 
 
 
 Th cells showed func-
tional capabilities of naive Th cells, in that they are both
able to produce considerable amounts of IL-2 (Fig. 3). In
addition, CD31
 
 
 
 and CD31
 
 
 
CD45RA
 
 
 
CD4
 
 
 
 T cell sub-
sets of all analyzed samples showed very low frequencies
(
 
 
 
1%) for the Th1 and Th2 effector cytokines IFN-
 
 
 
 and
IL-4 (Fig. 3, donor #1: a and b, donor #2: g and h),
whereas in the CD45RO
 
 
 
 memory/effector Th cells iso-
lated from the same donors frequencies of 11% (donor #1:
Fig. 3 c) and 24% (donor #2: Fig. 3 i) for IFN-
 
 
 
 
 
IL-4
 
 
 
cells and 1.2% (donor #1: Fig. 3 c) and 1.5% (donor #2:
Fig. 3 i) for IL-4
 
 
 
IFN-
 
 
 
 
 
 cells were detectable. Thus
CD45RA
 
 
 
CD45RO
 
 
 
 Th cells lacking CD31 expression
are naive Th cells with respect to both their phenotypic and
functional features. Consequently only an augmented pe-
ripheral naive Th cell homeostasis during ageing can ac-
count for the age dependent increase of peripheral
CD45RA
 
 
 
 Th cells lacking CD31.
 
TREC Analysis in CD31
 
 
 
 and CD31
 
 
 
CD45RA
 
 
 
 Th
Cells.
 
We tested this hypothesis directly by performing
quantitative PCR analysis of TREC numbers in highly pu-
 
rified peripheral CD31
 
 
 
 and CD31
 
 
 
CD45RA
 
 
 
CD45RO
 
 
 
Th cells from healthy adults. The isolation procedure in-
volved magnetic purification of CD4
 
 
 
 Th cells, and separa-
tion of CD31
 
 
 
 and CD31
 
 
 
CD45RA
 
 
 
CD45RO
 
 
 
 Th cells
and CD31
 
 
 
CD45RA
 
 
 
CD45RO
 
 
 
 memory/effector Th
cells by FACS
 
®
 
. Reanalysis of isolated subsets revealed puri-
ties higher than 94% for all samples (data not shown). Sam-
ples were taken from PBMCs of six healthy adult donors
between 24 and 52 yr. While 
 
 
 
40 TRECs per 10
 
3
 
 Th cells
were detected in cord blood Th cells, no TRECs were
measured in highly purified peripheral blood B cells, as
shown in Fig. 4. Naive CD45RA
 
 
 
 Th cells coexpressing
CD31 showed a TREC content on average 8 times higher
than the naive CD45RA
 
 
 
 Th cells lacking CD31 isolated
from the same donor (range: 3.9–39.5 times). As expected,
only very few TRECs were detected among CD45RO
 
 
 
Th cells in all analyzed samples (Fig. 4). In two samples (do-
nor #1, donor #3), the decrease in TRECs measured
among the CD31
 
 
 
 subset was analogous to that measured
among CD45RO
 
 
 
 memory/effector Th cells (Fig. 4). Ab-
solute TREC content in CD31
 
 
 
CD45RA
 
 
 
 Th cells was
an order of magnitude lower than TREC measurements in
thymic cells (data not shown). This reduction can be as-
cribed to proliferation during thymocyte maturation before
emigration into the periphery. Similar findings for TREC
levels have been obtained recently within sorted monkey
thymocyte and peripheral blood Th cell populations (22).
 
Discussion
 
We have identified here for the first time a subset of hu-
man naive Th cells within in adult peripheral blood which
has undergone extensive peripheral postthymic expansion.
Figure 3. Cytokine production of CD45RO CD45RA CD4  Th
cells, CD31  and CD31 CD45RA CD45RO  CD4  Th cell subsets
upon polyclonal in vitro stimulation. The CD45RO CD45RA  Th
cells, CD31  and CD31 CD45RA CD4  Th cell subsets were isolated
using MACS, stimulated for 6 h with PMA/Ionomycin, fixed with 2%
formalin, and stained for intracellular cytokines (IL-2, IFN- , IL-4). The
dot plots show the results of examined CD45RO CD45RA , CD31 
and CD31 CD45RA CD4  T cell subsets isolated from PBMCs of two
healthy individuals (a–f: donor #1, g–l: donor #2) representative for six
analyzed healthy individuals. The percentages of cytokine-positive cells
are given in each plot.
Figure 4. Quantification of TREC content among highly purified pe-
ripheral Th cell subsets from six healthy adults. Genomic DNA of sorted
subpopulations from six healthy adults was isolated and the number of
TRECs was determined by quantitative real-time PCR. White bars rep-
resent TREC content in the CD31 CD45RA CD45RO  Th cells,
gray bars represent TREC content in the CD31 CD45RA CD45RO 
Th cells and black bars represent the TREC content among
CD31 CD45RO CD45RA  Th cells. The highest TREC content
was detected in cord blood (striped bar) and no TRECs were detected
in B cells.793 Kimmig et al. Brief Definitive Report
We show directly that CD45RA  Th cells lacking CD31
are characterized by a drastically reduced content of
TRECs. Hence, CD31 is expressed on RTEs but appar-
ently lost during postthymic peripheral expansion of RTEs.
We also show that naive Th cells lacking CD31 increase in
frequency during ageing. However, these peripherally ex-
panded Th cells retain all phenotypic and functional fea-
tures of naive Th cells. Based on our results it is now possi-
ble to distinguish peripherally postthymically expanded
naive Th cells (centralnaive Th cells) from true recent thymic
emigrants (thymicnaive Th cells).
thymicNaive Th cells probably use CD31 for transendo-
thelial migration to enter secondary lymphoid organs, a
process that has recently been suggested to be essential for
homeostatic proliferation of T cells (23). Interestingly,
more recent investigations have shown that CD31 trigger-
ing leads to inhibition of TCR signaling via immunorecep-
tor tyrosine-based inhibitory motifs (ITIMs; reference 24).
It remains to be clarified whether CD31 indeed transduces
negative signals during postthymic naive T cell prolifera-
tion to control T cell activation after tickling of the TCR
with specific MHC/self-peptide ligands.
Taken together, the age-dependent increasing percent-
ages of peripheral CD31 CD45RA CD45RO  Th cells
(and concomitant age-dependent decrease of CD31 
CD45RA CD45RO  Th cells) and the drastic reduction
in absolute TREC numbers among the CD31  subset in all
analyzed donors, indicate that CD45RA  Th cells lacking
the CD31 molecule must have undergone extensive pe-
ripheral proliferation. We propose that after emigrating
from the thymus, thymicnaive CD31  Th cells may undergo
a peripheral, second positive selection to counterbalance
the age-dependent decreased thymic output and enter a
second pool of centralnaive CD31  Th cells (Fig. 5). Strik-
ingly, up to half of the naive Th cells in normal healthy
adults are characterized by the loss of CD31 expression and
since they are almost void of TRECs compared with their
CD31  counterparts represent peripherally expanded naive
Th cells. What are the signals responsible for peripheral ex-
pansion of naive Th-cells? MHC II molecules presenting
self peptides have been shown to trigger peripheral expan-
sion of naive Th cells (4–6, 25–28). Such a second post-
thymic peripheral positive selection must be tightly regu-
lated as potentially autoreactive T cells have to be
eliminated or controlled efficiently. As CD31 is lost during
in vitro stimulation of Th cells after TCR triggering (20),
we hypothesize that down-regulation of CD31 expression
on peripherally expanded naive Th cells could in fact be a
consequence of the TCR ligation with endogenous MHC
and self-peptides.
To summarize, we could show for a first time that the
human peripheral naive Th cell pool in adults consists of
two major parts. thymicNaive Th cells, characterized by high
TREC levels exist among CD31 CD45RA  Th cells. In
contrast, centralnaive Th cells lacking CD31 expression are
characterized by TREC levels which are lower by a factor
of up to 0.025 compared with their CD31  counterparts,
implying that centralnaive Th cells have extensively prolifer-
ated. Our results should facilitate further studies investigat-
ing how a naive TCR repertoire is maintained through
peripheral expansion. It remains to be clarified how the
processes during which Th cells are triggered by endoge-
nous MHC and self-peptides are controlled to avoid ex-
pansion and activation of autoreactive Th cells. Wagner et
al. have reported a possible perturbation of the naive Th
cell repertoire in rheumatoid arthritis patients (29). Previ-
ously it has also been reported that TRECs are substan-
tially reduced in naive Th cells from these patients, sug-
gesting a decreased thymic output or/and an increased
self-replication of naive Th cells (30). In this study we de-
fined phenotypic features distinguishing naive human Th
cells emigrating from the thymus from those naive human
Th cells which have undergone a further secondary pe-
ripheral expansion. We have shown that the subset of hu-
man peripheral CD45RA  Th cells coexpressing CD31
contains recent thymic emigrants, while the counterpart
population lacking CD31 expression represents Th cells
which have extensively proliferated most likely to com-
pensate for the reduced thymic output during ageing. Our
results enable direct access and thereby further functional
and molecular analysis of these two human peripheral na-
ive Th cell subsets.
We are grateful to S. Rose-John for critical reading and discussion
and M. Kessissoglou, M. Kimmig, and C. Scharek for support.
Submitted: 18 October 2001
Revised: 21 December 2001
Accepted: 14 January 2002
Figure 5. Model of peripheral naive Th cell homeostasis. Full thymic
activity in young healthy individuals leads to continuous replenishment
with naive Th cells with high TREC content. These recent thymic emi-
grants coexpress CD45RA and CD31. Upon activation with foreign anti-
gens thymic naive Th cells (thymicnaive Th cells) differentiate into CD31 
CD45RA CD45RO  memory/effector Th cells. During ageing thymic
activity decreases resulting in reduced absolute numbers of thymicnaive
Th cells. Upon triggering with self peptides and MHC thymicnaive Th cells
proliferate and differentiate into central naive Th cells (centralnaive Th cells)
to compensate for the reduced thymic output. centralNaive Th cells have
reduced TREC numbers and express CD45RA while they lack CD31 ex-
pression. Both thymicnaive and centralnaive Th cells are able to differentiate
into CD31 CD45RA CD45RO  memory/effector Th cells.794 The Human Adult Naive Th Cell Pool Consists of Two Major Subsets
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